PENG

PENG Up Your Profits: Gate.io Announces Trade-to-Earn Event Worth $5,000

Retrieved on: 
Friday, March 22, 2024
Partnership, PENG, UTC, Growth, Cryptocurrency

With a total of $5,000 in rewards up for grabs, this event promises an exciting opportunity for participants to dive into the world of $PENG trading and win big.

Key Points: 
  • With a total of $5,000 in rewards up for grabs, this event promises an exciting opportunity for participants to dive into the world of $PENG trading and win big.
  • "We are thrilled to partner with Gate.io for this exciting event," said a representative for $PENG.
  • The Gate.io X Peng (PENG) "Trade to Earn" Event invites traders to seize the opportunity to earn rewards simply by trading $PENG on the Gate.io platform.
  • As the event draws near, participants are encouraged to stay tuned for updates and announcements from both $PENG and Gate.io.

iQIYI's 'To the Wonder' Selected for CANNESERIES, Marking the First C-Drama in Long Form Competition

Retrieved on: 
Tuesday, March 12, 2024
QI, Head, Wonder, IQIYI, Magnolia, Art, Berlin International Film Festival, PENG, Tapie, Canneseries, CITY, Love, Best Actress, BBC America, Language, Television, Film industry

This marks the first Chinese language long-form drama series to be selected in this competition since its launch in 2018.

Key Points: 
  • This marks the first Chinese language long-form drama series to be selected in this competition since its launch in 2018.
  • To the Wonder is set for its world premiere in Cannes on April 7, where it will vie for five major awards against seven other international series.
  • The nominated mini-series is an adaptation of the award-winning essay collection My Altay by Juan LI, a renowned Chinese essayist.
  • These achievements highlight iQIYI's dedication to creating high-quality content that resonates with global audiences and underscore its growing influence in the international entertainment industry.

Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer

Retrieved on: 
Tuesday, August 8, 2023
Drug development, University, University of California, Davis, NDA, Cancer, Pfizer, Ng, Sale, PENG, Economics, PCSA, Research and development, Development, NGC, Metabolism, Patient, Bachelor of Arts and Science, Standard of care, Law, Science, FDA, Safety, Pharmaceutical industry, Processa edulis, Biochemistry, MD, Research

“We are thrilled to have George assume the leadership of our management team.

Key Points: 
  • “We are thrilled to have George assume the leadership of our management team.
  • Mr. Ng is a seasoned life sciences industry executive who joins Processa from his previous position as Board Director, President, and Chief Operating Officer at Calidi Biotherapeutics, Inc. Mr. Ng is also a partner at PENG Life Science Ventures (PENG LSV).
  • I believe George’s experience and background is exactly what we need to make my transition successful and move Processa forward while increasing shareholder value.
  • We are thankful to have continued shareholder support, and I believe having George lead our Company will help us improve our shareholder value in the future.”